Prescribe SYMBICORT for patients 12 years and older who are uncontrolled on an ICS or whose disease severity clearly warrants initiation of an ICS/LABA
Once asthma control is achieved and maintained, assess the patient at regular intervals and step down therapy (for example, discontinue SYMBICORT) if possible without loss of asthma control, and maintain the patient on a long-term asthma control medication, such as an ICS.
- The maximum daily recommended dose is 640/18 mcg budesonide/formoterol (given as 2 inhalations of SYMBICORT 160/4.5 twice daily) for patients 12 years and older. Do not use more than twice daily or use a higher number of inhalations (more than 2 inhalations twice daily) of the prescribed strength of SYMBICORT as this will result in a daily dose of formoterol in excess of the dose determined to be safe
- Patients who are receiving SYMBICORT should not use additional formoterol or other long-acting beta2-agonists for any reason